Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Radiologist claims he was shorted in $20M imaging center sale to private equity platform

Gregory R. Ball, MD, of Orchard Park, New York, and his attorneys filed the complaint against Southtowns Radiology Associates et al. on Feb. 24. 

RadNet CEO Howard Berger

RadNet sees rocky 2025 start, with severe weather leading to $22M revenue loss

Meanwhile, RadNet saw a strong finish to 2024, with a company record of $477 million in fourth quarter revenue. 

Biograph whole-body MRI

Biograph, a new whole-body MRI startup, launches with $7,500 membership fee

The company has already opened its first location in San Mateo, California, with another to follow in New York City, collecting over 1,000 datapoints from 30-plus exams.  

Federal Trade Comission FTC Sign logo

FTC inquiry pauses $615M healthcare staffing merger

The merger between Aya Healthcare and Cross Country Healthcare was finalized in December 2024 and was expected to close in the first half of this year. It's unclear what information the Federal Trade Commission requested from both companies. 

Thumbnail

UVA Health CEO steps down following internal investigation

Craig Kent served in his role for five years and resigned on Tuesday after an investigation into patient safety and hiring concerns followed employees signing a letter of no confidence.

Thumbnail

FDA sued over ‘reckless and arbitrary’ semaglutide decision

The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.

Teleflex to acquire Biotronik’s vascular intervention business for $791M, split into 2 separate entities

The acquisition helps Teleflex expand its interventional and vascular portfolios. Biotronik, meanwhile, is shifting its focus toward implantable devices and digital healthcare.